New Prevention Technologies Workshop - PowerPoint PPT Presentation

1 / 33
About This Presentation
Title:

New Prevention Technologies Workshop

Description:

New Prevention Technologies Workshop. Module 4: Who s Who. www.icad-cisd.com – PowerPoint PPT presentation

Number of Views:105
Avg rating:3.0/5.0
Slides: 34
Provided by: Goog6594
Category:

less

Transcript and Presenter's Notes

Title: New Prevention Technologies Workshop


1
www.icad-cisd.com
  • New Prevention Technologies Workshop
  • Module 4
  • Whos Who

2
Overview of Role of Various Players
3
Who?
Ethical Research
4
Who are the Players in HIV NPT Research?
  • Academic researchers and universities
  • Community members and organizations, community
    advisory boards
  • Private sector pharmaceutical and biotech
    companies
  • Government funders and regulators
  • Health care providers

5
Academic Researchers
  • Basic Researchers
  • lead the scientific discovery and development of
    NPT candidate concepts and products
  • Clinical Researchers
  • lead the clinical testing of candidate NPT
    products, testing efficacy as well as issues of
    acceptance and accessibility
  • establish and maintain the highest standards of
    ethical conduct of clinical trials
  • Social Researchers
  • conduct research on acceptability, preparedness,
    access and delivery issues
  • work alongside clinical research to understand
    usability and acceptance of NPTs

6
Community Roles
  • develop community acceptance and preparedness
    for NPTs
  • raise awareness about the role community based
    organizations can play before, during and after
    trials
  • facilitate clinical trial recruitment
  • incorporate NPTs into prevention education and
    training programs for specific vulnerable
    populations
  • develop strategies for promoting and distributing
    NPTs once available
  • advocate for investment in NPT research and
    development

7
Private Sector
  • invest in research and development, manufacturing
    and production
  • technical innovation
  • establish clinical infrastructure (e.g.,
    epidemiological laboratories, trials
    infrastructure) during the pre-clinical
    development of the NPT that will be needed in
    clinical research
  • translational research generate data, clinical
    materials

8
Government Funders and Regulators
  • provide funding for NPT research programs,
    academic researchers, conferences
  • coordinate domestic and global efforts
  • ensure that adequate clinical research facilities
    exist
  • ensure availability of properly trained staff
  • help build public awareness and support for
    research and development
  • achieve speedy and appropriate access once a NPT
    becomes available

9
Health Care Providers
  • monitoring, prevention and control of HIV/AIDS
    and STIs
  • help with NPT delivery, education and access
  • With ARV-based NPTs, may need to be prescribers

10
Community engagement
11
Locating Community
  • When we talk about community, it is important to
    frame the discussion in terms of
  • Who is included in the particular community we
    are discussing?
  • And distinguish which level we are referring to

12
(No Transcript)
13
Trial Participants Study Staff refers to
the individuals directly participating in the
trial, in some instances their partner(s), and
study staff working at the trial site.
14
Host Community refers to the individuals
living in the area of the trial, their leaders,
and community-based organizations that serve or
represent them directly. This can also include
traditional healers, local radio, and other
community structures (including CABs)
15
National Stakeholders describes anyone who
has a role to play in the political, scientific,
and social enterprise of microbicide development
in the larger, national community. It includes
political decision-makers, MoH, regulatory
bodies, ethical review committees, national NGOs,
donors, national media, etc.
16
International Civil Society refers to
non-profit, organized, citizen-led movements or
groups interested in the goals, process, and
outcomes of microbicide research, and/or in the
rights of communities or research participants.
Civil society includes international or
regional NGOs (GCM/UNAIDS), international or
media.
17
Community Involvement Strategies
  • Community advisory structures (CABs, CAGs, CACs,
    participant representatives)
  • Community preparedness
  • Community mappings
  • Radio local media
  • Dramas and community events
  • Network community working groups
  • Cross-network community involvement

18
Community Advisory Groups
  • Also Community Advisory Boards (CABs)
  • CAGs are now required by many research sponsors
    and trial networks
  • A CAG is a group of volunteers from the general
    public and from the diverse communities affected
    by a condition like HIV/AIDS
  • A CAG is organized to assist and advise
    researchers within a given network or site

19
(No Transcript)
20
  • Why is so much blood taken?
  • What do you do with the left over blood?
  • Are the needles safe/clean?

21
Authentic Community Involvement
Evolution of Norms for Community Involvement in
Research
Partnership and Mobilization Research
implementation exists alongside specific process
goals that strengthen the role and capacity of
community to articulate and address its own
development needs including future research
priorities.
Advisory Community representatives provide input
into specific areas of the study as requested by
the research team
Collaborative Community representatives and
research team cooperate in developing and
implementing the research
Historical No involvement of community except as
pool from which to draw research participants
  • Global Campaign for Microbicides

22
International and National Organizations
23
www.avac.org
AVAC uses education, policy analysis, advocacy
and community mobilization to accelerate the
ethical development and eventual global delivery
of HIV vaccines and other new HIV prevention
options.
24
www.global-campaign.org
A civil society organization that works to ensure
the ethical and accelerated development and
widespread access to new and existing
HIV-prevention optionsespecially for women. GCM
works to ensure that as research proceeds, the
rights and interests of women, potential
end-users, trial participants and communities are
represented and respected.
25
www.global-campaign.org/amag.htm
AMAG is a coalition of microbicides advocates
from organisations and institutions based in/or
working in various African countries, working to
ensure that a coordinated African voice is
engaged in setting and moving forward the
microbicides advocacy agenda.
26
www.rectalmicrobicides.org
IRMA works to advance a robust rectal microbicide
research and development agenda. IRMA works to
confront the institutional, socio-cultural and
political stigma around the public health need
for rectal microbicide research, and to increase
funding and commitment within this field of
inquiry.
27
www.hivvaccineenterprise.org
The Enterprise is a working group of scientists,
researchers, funders, government and industry
representatives, and advocates from around the
world to mobilize significant funding and
resources in order to accelerate the development
of an effective and safe preventive HIV vaccine.
28
www.iavi.org
To support the development of safe and effective
preventative HIV vaccines that are accessible for
use throughout the world.
29
www.hvtn.org
HVTN is an international collaboration of
scientists and educators searching for an
effective and safe HIV vaccine through
well-designed clinical research trials, which
objectively and ethically address all the
critical questions in all phases of clinical
trials.
30
www.ipmglobal.org
IPM is a non-profit product development
partnership (PDP) established to prevent HIV
transmission by accelerating the development,
availability and delivery of safe and effective
microbicides for use by women in developing
countries.
31
www.mtnstophiv.org
MTN is a worldwide collaborative clinical trials
network focused on preventing the sexual
transmission of HIV through the development and
evaluation of products that reduce the
transmission of HIV.
32
www.chvi-icvv.gc.ca
The overall goal of the CHVI is to support a
coordinated Canadian domestic and international
contribution to global efforts to accelerate the
development of a safe, effective, affordable and
globally accessible HIV vaccine.
33
www.icad-cisd.com
ICAD helps Canadians contribute to international
HIV/AIDS work and ensures that the lessons
learned from the global response to HIV/AIDS are
utilized by Canadian organizations to improve
prevention, care, treatment and support work in
Canada.
Write a Comment
User Comments (0)
About PowerShow.com